Discover 1,839 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,839
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
for
Glioblastoma, Recurrent Glioblastoma, GBM
Location: Tampa FL, Jacksonville FL, Miami FL, Atlanta GA,
Sponsor: CarThera
Sex: All
Age: 18+
Code: NCT05902169
Phase3, Recruiting
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
for
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
Location: Tampa FL, Orlando FL, Miami FL, Washington D.C. DC,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05208047
Phase3, Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Tampa FL, Nashville TN, Fairfax VA, St Louis MO,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase1, Recruiting
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
for
Advanced Solid Tumor, Non-Small Cell Lung Cancer,
Location: Tampa FL, Sarasota FL, Fairfax VA
Sponsor: Blueprint Medicines Corporation
Sex: All
Age: 18+
Code: NCT07629960
Phase1, Phase2, Recruiting
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
for
Breast Cancer
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT07357298
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
for
Relapsed or Refractory Large B-cell Lymphoma
Location: Tampa FL, Newnan GA, Charlotte NC, Nashville TN,
Sponsor: Kite, A Gilead Company
Sex: All
Age: 18+
Code: NCT07479797
Phase3, Recruiting
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT04975152
Phase1, Recruiting
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
for
Small Cell Lung Cancer
Location: Tampa FL, Memphis TN, Fairfax VA, New York NY, Zion IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07531095
Phase1, Recruiting
Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
for
Gastrointestinal Cancers
Location: Tampa FL, Nashville TN, San Antonio TX, Grand Rapids MI,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07539311
Phase2, Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Tampa FL, Jacksonville FL, Miami FL, Chapel Hill NC,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07406633
Phase2, Recruiting
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
for
Lymphoma
Location: Tampa FL, Nashville TN, Houston TX, Columbus OH,
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Sex: All
Age: 18+
Code: NCT07015242
Phase2, Recruiting
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
for
Colorectal Cancer, Gastric Adenocarcinoma,
Location: Tampa FL, Cincinnati OH, Boston MA, Salt Lake City UT,
Sponsor: Dispatch Biotherapeutics
Sex: All
Age: 18+
Code: NCT07544589
Phase1, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
for
Recurrent Glioblastoma, IDH-Wildtype,
Location: Tampa FL, Jacksonville FL, Deerfield Beach FL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05432804
Phase1, Phase2, Recruiting
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer
for
Ras-mutated Metastatic Colorectal Cancer, mCRC,
Location: Tampa FL, Atlanta GA, Homewood AL, Indianapolis IN,
Sponsor: Oncolytics Biotech
Sex: All
Age: 18+
Code: NCT07446322
Phase2, Recruiting
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
for
Non Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer,
Location: Tampa FL
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 18+
Code: NCT05681780
Phase1, Recruiting
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
for
Diffuse Large B-Cell Lymphoma, Not Otherwise Specified,
Location: Tampa FL, Winston-Salem NC, Charlottesville VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06015880
Phase1, Recruiting
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
for
KRAS-mutant Non-small Cell Lung Cancer (NSCLC),
Location: Tampa FL, Sarasota FL, Fairfax VA, Houston TX,
Sponsor: Kestrel Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07458347
Phase1, Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
for
Polycythemia Vera (PV), Myelofibrosis (MF),
Location: Tampa FL, Coral Springs FL, Nashville TN, Houston TX,
Sponsor: Prelude Therapeutics Incorporated
Sex: All
Age: 18+
Code: NCT07469891
Phase1, Recruiting
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
for
Metastatic Breast Cancer in the Liver
Location: Tampa FL, Columbus OH, Cleveland OH, Dallas TX
Sponsor: Delcath Systems Inc.
Sex: All
Age: 18+
Code: NCT06875128
Phase2, Recruiting
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC